These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 14681327)
1. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course. Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327 [TBL] [Abstract][Full Text] [Related]
2. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541 [TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Miettinen M; Lasota J Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
5. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439 [TBL] [Abstract][Full Text] [Related]
6. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumours. Miettinen M; Sarlomo-Rikala M; Lasota J Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of gastric stromal tumors. Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317 [TBL] [Abstract][Full Text] [Related]
10. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475 [TBL] [Abstract][Full Text] [Related]
12. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Agaimy A; Wünsch PH; Hofstaedter F; Blaszyk H; Rümmele P; Gaumann A; Dietmaier W; Hartmann A Am J Surg Pathol; 2007 Jan; 31(1):113-20. PubMed ID: 17197927 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B; Sökmensüer C Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [TBL] [Abstract][Full Text] [Related]
14. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR. Bernet L; Zuñiga A; Cano R Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Miettinen M; Sobin LH; Sarlomo-Rikala M Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809 [TBL] [Abstract][Full Text] [Related]
16. Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions. Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K Int J Mol Med; 2006 Dec; 18(6):1067-71. PubMed ID: 17089009 [TBL] [Abstract][Full Text] [Related]
17. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach. Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437 [TBL] [Abstract][Full Text] [Related]
18. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681 [TBL] [Abstract][Full Text] [Related]